Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07126795 · ClinicalTrials.gov registry record · Phase 1
Magnesium Sulfate in Pediatric Burn Dressing Changes
A Phase 1 study, sponsored by Hennepin Healthcare Research Institute.
- Not yet
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT07126795 is a Phase 1 study that has not yet begun recruiting, run by Hennepin Healthcare Research Institute. The registered enrollment target is 10 participants.
The verdict
NCT07126795, a Phase 1 study, has not yet begun recruiting, sponsored by Hennepin Healthcare Research Institute.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia/sedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and/or sedative requirements.
Interventions
- DRUG Normal Saline (0.9% NaCl)
- DRUG magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07126795
The ClinicalTrials.gov registry entry for NCT07126795 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline (0.9% NaCl) is the first listed.
NCT07126795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07126795 about?
NCT07126795 is a clinical study titled "Magnesium Sulfate in Pediatric Burn Dressing Changes". Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia/sedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and/or sedative requirements.
What is the current status of trial NCT07126795?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2026-01-01. Estimated completion is 2027-01-01.
What interventions are being tested in trial NCT07126795?
The interventions under investigation include: Normal Saline (0.9% NaCl) (DRUG), magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT07126795?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.